Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine

NCT02745392 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

365

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Migraine

Interventions

DRUG: ZP-Zolmitriptan
DRUG: Placebo

Sponsor

Zosano Pharma Corporation